StockpollyBeta
Get App

Categories·Healthcare·Pharmaceuticals

Prescription Drugs

Medicines that can only be purchased with a doctor's prescription.

−0.93% today·87 stocks

Stocks

By market cap · 87 stocks

  1. 1LLYEli LillyDeveloper of Mounjaro, Zepbound, and Foundayo$1.10T−1.77%
  2. 2JNJJohnson & JohnsonDeveloper of medicines and procedure-based medical technologies$649.40B−1.45%
  3. 3MRKMerckMaker of Keytruda, vaccines, and animal medicines$369.24B−0.26%
  4. 4NVSNovartis (ADR)Developer of focused innovative medicines$267.96B−0.00%
  5. 5AZNAstraZeneca (ADR)Oncology-led developer of specialty medicines$260.70B−0.28%
  6. 6NVONovo Nordisk (ADR)GLP-1 and insulin specialist$176.83B−1.22%
  7. 7PFEPfizerDeveloper of Eliquis, Prevnar and cancer medicines$158.10B−0.45%
  8. 8VRTXVertex PharmaceuticalsDeveloper of CFTR modulators and specialty medicines$129.62B−0.14%
  9. 9MCKMcKessonPharmaceutical distributor and specialty-care services provider$103.79B+0.48%
  10. 10GSKGSK (ADR)Developer of Shingrix, Nucala, and Trelegy$102.34B−1.12%
  11. 11SNYSanofi (ADR)Developer of Dupixent-led medicines and vaccines$102.05B−0.78%
  12. 12REGNRegeneronMaker of Dupixent, EYLEA HD, and Libtayo$82.23B−0.20%
  13. 13CORCencoraGlobal pharmaceutical distribution and specialty-care services$61.58B+0.05%
  14. 14TAKTakeda (ADR)Developer of ENTYVIO and plasma-derived therapies$60.11B−0.19%
  15. 15TEVATeva (ADR)Maker of global generics and neuroscience medicines$46.66B−1.12%
  16. 16RPRXRoyalty PharmaBuyer and funder of drug royalties$25.90B−0.59%
  17. 17VTRSViatrisGlobal maker of established brands and generics$19.91B−0.38%
  18. 18ASNDAscendis Pharma (ADR)TransCon medicines for rare endocrine disorders$14.76B+0.19%
  19. 19CORTCorcept TherapeuticsCortisol-modulation medicines for endocrine disease and cancer$12.30B+1.09%
  20. 20RDYDr. Reddy's Laboratories (ADR)Maker of global generics and pharmaceutical ingredients$10.33B+1.65%
  21. 21ALKSAlkermesNeuroscience medicines for addiction, psychiatry and sleep$7.41B+0.15%
  22. 22AMRXAmneal PharmaceuticalsManufacturer of generics, biosimilars, and specialty medicines$6.44B−1.59%
  23. 23LQDALiquidiaInhaled treprostinil specialist for pulmonary hypertension$5.91B+0.05%
  24. 24DFTXDefinium TherapeuticsDeveloper of lysergide and R(-)-MDMA medicines$5.21B−0.08%
  25. 25INDVIndiviorDeveloper of SUBLOCADE opioid-use-disorder treatment$4.43B+0.46%
  26. 26OGNOrganonWomen's health, biosimilars, and established medicines$3.59B+0.04%
  27. 27TARSTarsus PharmaceuticalsMaker of XDEMVY for Demodex blepharitis$3.33B+0.06%
  28. 28HCMHUTCHMED (ADR)Targeted cancer and immunology medicines$2.53B−2.40%
  29. 29SUPNSupernus PharmaceuticalsDeveloper of ADHD, Parkinson’s, and postpartum depression medicines$2.48B+0.68%
  30. 30TRVITrevi TherapeuticsHaduvio developer targeting chronic cough$2.11B+1.31%
  31. 31ANIPANI PharmaceuticalsMaker of Cortrophin and niche generic drugs$1.79B−0.28%
  32. 32ETONEton PharmaceuticalsRare-disease therapy developer and commercializer$1.52B+0.18%
  33. 33OMEROmerosComplement drug developer with YARTEMLEA launch$1.34B+8.56%
  34. 34LTGOLatigo BiotherapeuticsDeveloper of non-opioid NaV1.8 pain medicines$1.27B−0.68%
  35. 35HROWHarrowOphthalmic medicines and compounding$1.26B+0.94%
  36. 36OPKOPKO HealthBioReference diagnostics and biopharma operator$1.26B+2.07%
  37. 37MNKDMannKindInhaled insulin and cardiometabolic therapies$1.12B−4.43%
  38. 38AMPHAmphastar PharmaceuticalsMaker of complex generic and branded injectable drugs$1.08B+0.06%
  39. 39GYREGyre TherapeuticsMaker of ETUARY, China's lung-fibrosis therapy$828.4M−0.27%
  40. 40ACHVAchieve Life SciencesDeveloper of cytisinicline for nicotine dependence$826.4M+1.18%
  41. 41COLLCollegium PharmaceuticalADHD and pain medicines portfolio$747.3M+1.00%
  42. 42ZVRAZevra TherapeuticsDeveloper of rare-disease treatments for NPC and UCD$689.9M+0.04%
  43. 43AQSTAquestive TherapeuticsPharmFilm developer for rescue medicines$599.7M+1.78%
  44. 44RLMDRelmada TherapeuticsDeveloper of bladder cancer and CNS therapies$436.3M+1.08%
  45. 45EYPTEyePointRetinal drug-delivery therapy developer$337.0M+1.62%
  46. 46CUVLClinuvel Pharmaceuticals (ADR)SCENESSE®-centered melanocortin drug developer$292.5M+1.23%
  47. 47DBVTDBV Technologies (ADR)Developer of the Viaskin Peanut Patch$289.5M−0.37%
  48. 48AMRNAmarin (ADR)Commercializer of Vascepa cardiovascular therapy$278.8M+0.96%
  49. 49ANIKAnika TherapeuticsHA orthopedics for OA pain$277.0M−0.63%
  50. 50SIGASIGASmallpox antiviral for government stockpiles$226.6M+0.63%